Results 61 to 70 of about 114,570 (194)
Outcome after kidney transplantation in hepatitis B surface antigen-positive patients
Few reports detail the actual outcome of Hepatitis B Surface Antigen-positive patients after kidney transplant. HBsAg-positive patients who underwent kidney transplant between January, 1999, and December, 2018, were reviewed retrospectively.
Hyejin Mo +4 more
doaj +1 more source
Abstract Aging of population and emerging infectious diseases increasingly threaten stable blood supply, underscoring the need for alternative blood sources. Porcine red blood cells (pRBCs) offer notable advantages over human RBCs, including morphological and physiological similarity, established pathogen‐free breeding systems, and freedom from ABO ...
Juhye Roh, Hee Jung Kang
wiley +1 more source
Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients
Imlifidase is a cysteine proteinase which specifically cleaves IgG, inhibiting Fc-mediated effector function within hours of administration. Imlifidase converts a positive crossmatch to a potential donor (T cell, B cell, or both), to negative, enabling ...
Desai, Niraj M +46 more
core +1 more source
Introduction: With the increased utilization of immunohematology (IH) analyzers in the transfusion medicine, type, and screen policy is the method of choice. Still, the importance of routine crossmatching could not be overruled.
Prasun Bhattacharya +4 more
doaj +1 more source
Impact of ABO Incompatibility on the Development of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients Presensitized to HLA. [PDF]
Whether the coexistence of anti-A/B antibody and donor specific anti-HLA antibody (HLA-DSA) has a synergistic impact on the development of acute antibody-mediated rejection (AAMR) in kidney transplant recipients (KTRs) is unclear.
Byung Ha Chung +10 more
doaj +1 more source
Pneumocystis jirovecii (PJ) opportunistic infections occur in immunocompromised patients impacting significantly hospitalizations and mortality. Trimethoprim-sulfamethoxazole (TMP-SMX) is universally used as prophylaxis of Pneumocystis jirovecii ...
Círia Leandra Martins de Sousa +4 more
doaj +1 more source
Background. Human leukocyte antigen (HLA) antibody-incompatible renal transplantation has been increasingly performed since 2000 but with few data on the medium-term outcomes. Methods.
Rizwan Hamer +31 more
core +1 more source
ANALISIS INCOMPATIBLE PADA PEMERIKSAAN UJI SILANG SERASI (CROSS MATCHING) DENGAN METODE GEL TEST DI UTD PALANG MERAH INDONESIA KOTA MEDAN TAHUN 2023 [PDF]
Uji silang serasi (cross matching) adalah prosedur mencocokkan darah resipien dengan darah donor untuk mengetahui ecocokan antara antigen eritrosit donor dengan antibodi pada serum pasien dan sebaliknya yang bertujuan mencegah reaksi transfusi hemolitik.
Napitupulu, David Sumanto +2 more
core +1 more source
Overcoming Drug Interference in Transfusion Testing: A Spotlight on Daratumumab
Marilyn T Nedumcheril,1,2 Robert A DeSimone,1 Sabrina E Racine-Brzostek,1 Ok Kyong Chaekal,1,3 Ljiljana V Vasovic1 1Department of Pathology and Laboratory Medicine, New York-Presbyterian Hospital, Weill Cornell Medicine, New York, NY, USA; 2New York ...
Nedumcheril MT +4 more
doaj
Outcome of type and screen versus crossmatch in cardiovascular surgery patients: A comparative study
BACKGROUND: The need for an anti-human globulin (AHG) cross-match (XM) when the antibody screen (ABS) is negative is debatable and a matter of policy.
Anupa Pokhrel +3 more
doaj +1 more source

